JetBlue Airways Valuation
Is JBLU * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
2/6Valuation Score 2/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of JBLU * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: Insufficient data to calculate JBLU *'s fair value for valuation analysis.
Significantly Below Fair Value: Insufficient data to calculate JBLU *'s fair value for valuation analysis.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for JBLU *?
Other financial metrics that can be useful for relative valuation.
What is JBLU *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.95b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.6x |
Enterprise Value/EBITDA | 11.9x |
PEG Ratio | n/a |
Price to Sales Ratio vs Peers
How does JBLU *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 2.2x | ||
VOLAR A Controladora Vuela Compañía de Aviación. de | 0.2x | 0.9% | Mex$14.6b |
AEROMEX * Grupo Aeroméxico. de | 0.3x | n/a | Mex$22.8b |
OMA B Grupo Aeroportuario del Centro Norte. de | 4.2x | 9.2% | Mex$62.8b |
ALEATIC * Aleatica. de | 4.1x | n/a | Mex$60.6b |
JBLU * JetBlue Airways | 0.2x | 5.4% | Mex$1.9b |
Price-To-Sales vs Peers: JBLU * is good value based on its Price-To-Sales Ratio (0.2x) compared to the peer average (2.8x).
Price to Earnings Ratio vs Industry
How does JBLU *'s PE Ratio compare vs other companies in the Global Airlines Industry?
Price-To-Sales vs Industry: JBLU * is good value based on its Price-To-Sales Ratio (0.2x) compared to the Global Airlines industry average (0.6x).
Price to Sales Ratio vs Fair Ratio
What is JBLU *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.2x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate JBLU *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | Mex$104.00 | Mex$107.66 +3.5% | 30.0% | Mex$160.94 | Mex$53.65 | n/a | 13 |
Jun ’25 | Mex$90.01 | Mex$102.09 +13.4% | 30.0% | Mex$152.61 | Mex$50.87 | n/a | 13 |
May ’25 | Mex$97.93 | Mex$106.14 +8.4% | 29.1% | Mex$154.90 | Mex$51.63 | n/a | 13 |
Apr ’25 | Mex$123.35 | Mex$93.55 -24.2% | 31.5% | Mex$149.08 | Mex$49.69 | n/a | 12 |
Mar ’25 | Mex$110.00 | Mex$94.26 -14.3% | 33.7% | Mex$153.56 | Mex$51.19 | n/a | 11 |
Feb ’25 | Mex$91.25 | Mex$80.31 -12.0% | 24.8% | Mex$119.61 | Mex$51.26 | n/a | 10 |
Jan ’25 | Mex$94.50 | Mex$83.04 -12.1% | 21.6% | Mex$104.39 | Mex$52.20 | n/a | 11 |
Dec ’24 | Mex$74.88 | Mex$80.90 +8.0% | 20.6% | Mex$103.18 | Mex$51.59 | n/a | 11 |
Nov ’24 | Mex$67.40 | Mex$91.90 +36.3% | 19.6% | Mex$124.69 | Mex$71.25 | n/a | 11 |
Oct ’24 | Mex$81.50 | Mex$107.73 +32.2% | 20.0% | Mex$131.66 | Mex$70.22 | n/a | 11 |
Sep ’24 | Mex$103.00 | Mex$117.31 +13.9% | 21.8% | Mex$153.82 | Mex$76.91 | n/a | 11 |
Aug ’24 | Mex$120.50 | Mex$130.29 +8.1% | 19.8% | Mex$151.75 | Mex$75.88 | n/a | 11 |
Jul ’24 | Mex$152.00 | Mex$144.44 -5.0% | 15.3% | Mex$188.44 | Mex$102.78 | n/a | 11 |
Jun ’24 | Mex$122.40 | Mex$148.49 +21.3% | 14.5% | Mex$195.83 | Mex$106.82 | Mex$90.01 | 11 |
May ’24 | n/a | Mex$154.24 0% | 15.1% | Mex$199.07 | Mex$108.59 | Mex$97.93 | 11 |
Apr ’24 | Mex$125.75 | Mex$162.79 +29.5% | 10.7% | Mex$185.57 | Mex$129.90 | Mex$123.35 | 11 |
Mar ’24 | Mex$149.30 | Mex$164.70 +10.3% | 10.2% | Mex$185.82 | Mex$130.07 | Mex$110.00 | 11 |
Feb ’24 | Mex$149.07 | Mex$164.57 +10.4% | 10.7% | Mex$187.59 | Mex$131.32 | Mex$91.25 | 11 |
Jan ’24 | Mex$125.00 | Mex$173.43 +38.7% | 15.2% | Mex$217.46 | Mex$118.61 | Mex$94.50 | 11 |
Dec ’23 | Mex$150.00 | Mex$176.24 +17.5% | 16.5% | Mex$215.41 | Mex$117.50 | Mex$74.88 | 10 |
Nov ’23 | Mex$158.50 | Mex$179.16 +13.0% | 16.5% | Mex$217.76 | Mex$118.78 | Mex$67.40 | 10 |
Oct ’23 | Mex$139.60 | Mex$186.65 +33.7% | 13.4% | Mex$203.99 | Mex$122.39 | Mex$81.50 | 10 |
Sep ’23 | Mex$155.00 | Mex$195.48 +26.1% | 20.6% | Mex$277.84 | Mex$119.07 | Mex$103.00 | 10 |
Aug ’23 | Mex$175.45 | Mex$233.56 +33.1% | 26.7% | Mex$328.52 | Mex$123.19 | Mex$120.50 | 8 |
Jul ’23 | n/a | Mex$273.32 0% | 24.0% | Mex$404.91 | Mex$182.21 | Mex$152.00 | 8 |
Jun ’23 | Mex$201.50 | Mex$277.79 +37.9% | 18.8% | Mex$405.54 | Mex$202.77 | Mex$122.40 | 10 |
Analyst Forecast: Target price is less than 20% higher than the current share price.